4703-32-6

Basic information

• Product Name: L-Tyrosine, N-[(4-methylphenyl)sulfonyl]-
• CAS NO: 4703-32-6
• Molecular Formula: C16H17NO5S
• Molecular Weight: 335.381
• Mol File: 4703-32-6.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: L-Tyrosine, N-[(4-methylphenyl)sulfonyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: L-Tyrosine, N-[(4-methylphenyl)sulfonyl]-(4703-32-6)
• EPA Substance Registry System: L-Tyrosine, N-[(4-methylphenyl)sulfonyl]-(4703-32-6)

Safety Data

• Hazardous Substances Data: 4703-32-6(Hazardous Substances Data)

Upstream product

• 101585-61-9 N-tosyl L-tyrosine methyl ester 
• 60-18-4 L-tyrosine 
• 98-59-9 p-toluenesulfonyl chloride 
• 4089-07-0 L-tyrosine ethyl ester monohydrochloride 
• 13504-90-0 (S)-2-((4-methylphenyl)sulfonamido)-3-(4-(tosyloxy)phenyl)propanoic acid 
• 58559-09-4 Ethyl N-(p-tosyl)tyrosinate 

Downstream Products

• 122702-30-1 (2S,3S)-2-[(S)-2-(Benzyloxycarbonyl-methyl-amino)-3-(4-benzyloxycarbonyloxy-phenyl)-propionylamino]-3-methyl-pentanoic acid methyl ester 
• 122389-32-6 (S)-2-(Benzyloxycarbonyl-methyl-amino)-3-(4-benzyloxycarbonyloxy-phenyl)-propionic acid 4-nitro-phenyl ester 
• 91650-46-3 (S)-2-(Benzyloxycarbonyl-methyl-amino)-3-(4-benzyloxycarbonyloxy-phenyl)-propionic acid 
• 109369-51-9 (S)-2-Methylamino-3-[4-(toluene-4-sulfonyloxy)-phenyl]-propionic acid 
• 110055-30-6 (S)-3-(4-Hydroxy-phenyl)-2-methylamino-propionic acid tert-butyl ester 
• 537-49-5 N-methyl-L-tyrosine 
• 94917-43-8 (R)-3-Carboxymethylsulfanyl-2-[(S)-3-(4-hydroxy-phenyl)-2-(toluene-4-sulfonylamino)-propionylamino]-propionic acid 
• 94680-08-7 (R)-2-[(S)-3-(4-Hydroxy-phenyl)-2-(toluene-4-sulfonylamino)-propionylamino]-3-methylsulfanyl-propionic acid 
• 96070-56-3 (R)-3-Benzylsulfanyl-2-[(S)-3-(4-hydroxy-phenyl)-2-(toluene-4-sulfonylamino)-propionylamino]-propionic acid 
• 95281-81-5 (S)-2-[(S)-3-(4-Hydroxy-phenyl)-2-(toluene-4-sulfonylamino)-propionylamino]-4-methylsulfanyl-butyric acid 
• 101728-84-1 3,5-bis-chloromethyl-N-(toluene-4-sulfonyl)-tyrosine 
• 333999-59-0 (1S,3S,6S,7S,8R,9R)-7-acetoxy-6-(4-methoxybenzyl)-3-[N-methyl-N-(4-methylphenyl)sulfonylamino]-9-[(4-nitrophenyl)sulfonyloxy]-5-azatricyclo[6.3.1.0^1,5]dodecan-4-one 
• 333999-60-3 (1S,3S,6S,7S,8S,9S)-7,9-diacetoxy-6-(4-methoxybenzyl)-3-[N-methyl-N-(4-methylphenyl)sulfonylamino]-5-azatricyclo[6.3.1.0^1,5]dodecan-4-one 
• 361520-02-7 (3S,1S')-1-{2'-hydroxy-1'-[4-(3-methyl-but-2-enyloxy)benzyl]-ethyl}-3-[N-2,2,2-trichloroethoxycarbonyl-N-methyl-amino]-1-azaspiro[4.5]decane-8-ol 

Relevant articles and documents

Development of amino acid conjugated sulfonamides as potent antiulcer agent

A series of 2-{[(4-methylphenyl) sulfonyl] amino}-3-sulfanylpropanoic acid (1a) and its analogs 1b-j have been synthesized. These compounds were screened for their in vivo efficacy in pyloric ligation model. Compounds 1a and 1b with higher antiulcer potential were further screened in other gastric models to explore the mode of antiulcer action. To further understand the mode of action, in vitro inhibition of H+/K+ ATPase activity in gastric microsome isolated from rat stomach was studied. This was rationalized by in silico experiments.

HIV protease inhibitors based on amino acid derivatives

A compound selected from the group consisting of a compound of formula I 1a compound of formula II 2and when the compound of formula I and II comprises an amino group pharmaceutically acceptable ammonium salts thereof, wherein R1, R2, Cx, n, R3, R4, R5, Y are as defined in the specification.

Total synthesis of FR901483

The total synthesis of FR901483, a structurally novel immunosuppressant, has been accomplished by the use of technology recently developed in this laboratory for the oxidative cyclization of phenolic oxazolines to spirolactams. Our approach may reflect th